Insulet wins FDA clearance for Omnipod 5 algorithm enhancements
December 4, 2025
Insulet (Nasdaq: PODD)+
announced today that it received FDA 510(k) clearance for new enhancements to its Omnipod 5 system.
Insulet (Nasdaq: PODD)+
announced today that it received FDA 510(k) clearance for new enhancements to its Omnipod 5 system.
Atraverse Medical announced today that it received FDA clearance for its fully integrated Hotwire transseptal access system.
Boston Scientific (NYSE: BSX)+
announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) catheter.